Search Results 1681-1690 of 18718 for autoimmune hepatitis

  1. A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab - Mayo Clinic

    hepatitis B virus (HBV) or hepatitis C virus (HCV) infection at screening (positive HBV surface antigen or HCV RNA if anti-HCV antibody screening test is ...

  2. Benazepril (oral route) - Mayo Clinic

    Collagen vascular disease (an autoimmune disease) together with kidney disease—Increased risk of blood problems. ... Liver disease (including cirrhosis)—Use with ...

  3. LGI 1 IgG Associated Autoimmune Encephalitis Natural History Study - Mayo Clinic

    The purpose of this study is to perform retrospective data collection for a natural history study of LGI1 IgG seropositive patients seen at Mayo Clinic sites or ...

  4. A Study to Evaluate the Effectiveness, Safety and Tolerability of Efgatigimod PH20 SC in Adults with Pemphigus - Mayo Clinic

    autoimmune blistering disease. 2. Participants ... medication abuse. 13. Any other known autoimmune ... following conditions: Hepatitis B Virus, Hepatitis C Virus , ...

  5. A Study of Outpatients with Cirrhosis - Mayo Clinic

    In a patient with chronic liver disease. Fibroscan > 14.6 kPa. Platelet ... Acute Alcoholic hepatitis. Active malignancy other than HCC. HCC outside ...

  6. Liver cancer - Doctors and departments - Mayo Clinic

    ... liver disease. Show more areas of focus for ... ing cholangitis, Hepatitis B, Cholangiocarcinoma, Portal hypertension, Liver cancer, Alcoholic hepatitis ...

  7. Publications - Lauren F. Alexander, M.D. - Mayo Clinic

    Using qualitative descriptors of chronic liver disease on MRI: A practice prone to error. Clin Imaging. 2021 Jun; 74:89-92 Epub 2021 Jan 09. View PubMed ...

  8. Ulcerative colitis - Symptoms and causes - Mayo Clinic

    Digestive and Liver Disease. 2022; doi:10.1016/j.dld.2022.01.123. Xeljanz, Xeljanz XR (tofacitinib): Drug safety communication — Initial safety trial ...

  9. A Study to Evaluate Effectiveness and Safety of Lenzilumab in Hospitalized Patients with COVID-19 Pneumonia (Enrolling by Invitation Only) - Mayo Clinic

    Currently receiving treatment for hepatitis A, hepatitis B, hepatitis C or HIV infection. History of pulmonary alveolar proteinosis (PAP). Women of ...

  10. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

    Active autoimmune disease that has required ... Known history of human immunodeficiency virus (HIV) or active infection with hepatitis C virus (HCV) or hepatitis ...